Tralokinumab

Basic Information


CAS ID: 1044515-88-9
Molecular Formula:
Molecular Weight: g/mol
Monoisotopic Mass: g/mol
Class: Monoclonal antibody
Natural Product: No
Other Names:
Analysis: N/A


Compound Structure and Identifier


InChI: See All
InChI Key:
Smiles: See All
Molfile:


Related Target


Target ID Name Interaction
T0065 Interleukin-13 binder

Related Fibrosis Property


Reference Record 1

PubMed ID 24325475 Target ID T0065
Uniprot ID Interleukin-13 Name Interleukin-13
Model human,mice Fibrosis Disease Idiopathic pulmonary fibrosis
Process I
Process II
Process III prevenet collagen deposition
Mechanism

Trial Record 1

ClinicalTrial ID NCT01629667 Disease Idiopathic pulmonary fibrosis
Phase Phase 2 Status Terminated
First Received June 27, 2012 Last Verified May 15, 2017
Sponsor MedImmune LLC

Trial Record 2

ClinicalTrial ID NCT02036580 Disease Idiopathic pulmonary fibrosis
Phase Phase 2 Status Completed
First Received January 15, 2014 Last Verified February 23, 2017
Sponsor AstraZeneca

Related Link


PubChem: 135339998
ChEMBL: